JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2003, 52(6):295-298

The Release of Diltiazemiumchloride and Ibuprofen from Hydrophilic Matrix Tablets

L. Vostalová, M. Rabišková, G. Medvecká
Ústav technologie léků Farmaceutické fakulty Veterinární a farmaceutické univerzity, Brno

Hydrophilic matrix tablets based on hydroxypropylmethylcellulose (HPMC) and other cellulosederivatives rank among dosage forms with retarded effect widely used in contemporary pharmacotherapy.The active ingredient is released from them in dependence on its properties either bydissolution and diffusion, or erosion of the compact. The dissolution profile of the active ingredientcan be influenced by variables of formulation and manufacture, e.g. by the type of HPMCemployed,its concentration, other added auxiliary substances, and compression force which is reflected in thestrength of tablets.Two drugs with different solubility were used to study the effect of drug solubilityon its release frommatrices: well soluble diltiazemiumchloride and badly soluble ibuprofen. Highersolubility of the drug and lower solubility of compacts resulted in more rapid release of the activeingredient. Also lower concentration of HPMCaccelerates the release of both drugs. The effect of thedegree of viscosity of the polymer on drug release was not markedly manifested.

Keywords: hydrophilic matrices; hydroxypropylmethylcellulose; drug solubility; strength of tablets; modified release

Published: June 1, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vostalová L, Rabišková M, Medvecká G. The Release of Diltiazemiumchloride and Ibuprofen from Hydrophilic Matrix Tablets. Čes. slov. farm. 2003;52(6):295-298.
Download citation




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.